Highlighting rotavirus (RV) as a significant food and waterborne pathogen, particularly affecting infants and children, causing serious gastrointestinal infections and dehydration, is important. It should be noted that there are significant debates regarding the effectiveness and outcomes of RV vaccination. In contrast to Turkey’s nonmandatory vaccination policy, many developed countries implement mandatory vaccination policies, raising questions about their impact on disease prevalence and healthcare expenditures. Our study aims to comprehensively understand RV infections in Turkey and compare them with countries that have mandatory vaccination policies. We found similar, and even better, hospitalization rates, length of hospital stays, and laboratory parameters demonstrating the effectiveness of Turkey’s independent vaccination approach. These findings contribute valuable insights to global vaccination strategies and disease control.
Get full access to this article
View all access options for this article.
References
1.
ArslanA, CicekC, AksoylarS, et al.Investigation of the prevalence of rotavirus and norovirus in patients with acute diarrhea. FLORA, 2019; 24(2):113–118; doi: 10.5578/flora.67708
2.
BarsoumZ. Regional hospitalisation and seasonal variations of pediatric rotavirus gastroenteritis pre-and post-RV vaccination: A prospective and retrospective study. World J Pediatr, 2022; 18(6):404–416; doi: 10.1007/s12519-022-00546-0
3.
Bruijning-VerhagenP, SankatsingV, KunstA, et al.Rotavirus-related hospitalizations are responsible for high seasonal peaks in all-cause pediatric hospitalizations. Pediatr Infect Dis J, 2012; 31(12):e244–9–e249; doi: 10.1097/INF.0b013e31826a5ba1
4.
BurnettE, ParasharUD, TateJE. Real-world effectiveness of rotavirus vaccines, 2006–19: A literature review and meta-analysis. Lancet Glob Health, 2020; 8(9):e1195–e1202; doi: 10.1016/S2214-109X(20)30262-X
5.
ClarkA, JitM, AndrewsN, et al.Evaluating the potential risks and benefits of infant rotavirus vaccination in England. Vaccine, 2014; 32(29):3604–3610; doi: 10.1016/j.vaccine.2014.04.082
6.
de PalmaO, CruzL, RamosH, et al.Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: Case-control study. BMJ, 2010; 340:c2825; doi: 10.1136/bmj.c2825
7.
DesaiR, CurnsAT, SteinerCA, et al.All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000–2009. Clinical Infectious Diseases, 2012; 55(4):e28–e34.
8.
DhaliwalS, HoffmannS, WhiteA, et al.Cost of hospitalizations for leading foodborne pathogens in the United States: İdentification by international classification of disease coding and variation by pathogen. Foodborne Pathog Dis, 2021; 18(11):812–821; doi: 10.1089/fpd.2021.0028
9.
Díez-DomingoJ, Garcés-SánchezM, Giménez-SánchezF, et al.What have we learnt about rotavirus in Spain in the last 10 years? An. An Pediatr (Engl Ed), 2019; 91(3):166–179; doi: 10.1016/J.Anpedi.2019.01.024
10.
DonaD, MozzoE, ScamarciaA, et al.Community-acquired rotavirus gastroenteritis compared with adenovirus and norovirus gastroenteritis in Italian children: A pedianet study. Int J Pediatr, 2016; 2016:5236243; doi: 10.1155/2016/5236243
11.
FerriG, VergaraA. Hepatitis E virus in the food of animal origin: A review. Foodborne Pathog Dis, 2021; 18(6):368–377; doi: 10.1089/fpd.2020.2896
12.
García-MagánC, de Castro-LópezMJ, Llovo-TaboadaJ, et al.Microbiological profile of acute viral gastroenteritis attended in a paediatric department of an area with high vaccine cover against rotavirus. Enferm Infecc Microbiol Clin, 2014; 32(4):246–249; doi: 10.1016/j.eimc.2013.09.008
13.
GurgelRG, BohlandAK, VieiraSC, et al.Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program. Gastroenterology, 2009; 137(6):1970–1975; doi: 10.1053/j.gastro.2009.07.046
14.
HallowellBD, TateJ, ParasharU. An overview of rotavirus vaccination programs in developing countries. Expert Rev Vaccines, 2020; 19(6):529–537; doi: 10.1080/14760584.2020.1775079
15.
HeinsbroekE, HungerfordD, CookeRPD, et al.Do hospital pressures change following rotavirus vaccine introduction? A retrospective database analysis in a large paediatric hospital in the UK. BMJ Open, 2019; 9(5):e027739; doi: 10.1136/bmjopen-2018-027739
16.
IndrawanM, ChendanaJ, HandokoTGH, et al.Clinical factors predicting rotavirus diarrhea in children: A cross-sectional study from two hospitals. World J Clin Pediatr, 2023; 12(5):319–330; doi: 10.5409/wjcp.v12.i5.319
17.
KaiserP, BorteM, ZimmerK-P, et al.Complications in hospitalized children with acute gastroenteritis caused by rotavirus: A retrospective analysis. Eur J Pediatr, 2012; 171(2):337–345; doi: 10.1007/s00431-011-1536-0
18.
KaraayvazS. Vaccines outside the national immunization schedule. Nobel Tip Kitapevi, 2021:15–21.
19.
KılıcaslanO, SavNM., SahinİE., et al.Rol e of routine laboratory markers in the diagnosis of rotavirus and adenoviru s gastroenteritis. J Med Sci Res, 2022; 10(2):76–81; doi: 10.1772/7/JMSR.2022/10-15
20.
MortonVK, ThomasMK, McewenSA. Estimated hospitalizations attributed to norovirus and rotavirus infection in Canada, 2006–2010. Epidemiol Infect, 2015; 143(16):3528–3537; doi: 10.1017/S0950268815000734
21.
Nitsch-OsuchA, KucharE, KosmalaA, et al.Nosocomial rotavirus gastroenterocolitis in a large tertiary paediatric hospital in Warsaw, 2006-2010. Arch Med Sci, 2013; 9(3):493–498; doi: 10.5114/aoms.2013.33177
22.
ParezN, GiaquintoC, Du RoureC, et al.Rotavirus vaccination in Europe: Drivers and barriers. Lancet Infect Dis, 2014; 14(5):416–425; doi: 10.1016/j.patbio.2011.04.002
23.
ParkerEP, RamaniS, LopmanBA, et al.Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol, 2018; 13(1):97–118; doi: 10.2217/fmb-2017-0128
24.
PatelM, PedreiraC, De OliveiraLH, et al.Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA, 2009; 301(21):2243–2251; doi: 10.1001/jama.2009.756
25.
PietschC, LiebertUG. Rotavirus vaccine effectiveness in preventing hospitalizations due to gastroenteritis: A descriptive epidemiological study from Germany. Clin Microbiol Infect, 2019; 25(1):102–106; doi: 10.1016/j.cmi.2018.03.046
26.
RinderM, TranAN, BennetR, et al.Burden of severe rotavirus disease leading to hospitalization assessed in a prospective cohort study in Sweden. Scand J Infect Dis, 2014; 46(4):294–302; doi: 10.3109/00365548.2013.876511
27.
SeyboltLM, BéguéRE. Rotavirus vaccination and herd immunity: An evidence-based review. PHMT, 2012:25–37; doi: 10.2147/PHMT.S25705
28.
SrivastavaP, PrasadP. Human norovirus detection: How much are we prepared? Foodborne Pathog Dis, 2023; 20(12):531–544; doi: 10.1089/fpd.2023.0024
29.
StojkovskaS, JoksimovicB, VidinicI, et al.Evaluation of a rotavirus acute gastroenteritis severity score in hospitalized children over a ten year period in a clinic of infectious diseases, Skopje, R. Macedonia. Vaccine, 2013(15):17.
30.
ZaitoonH, HannaS, BambergerE. Impact of rotavirus vaccine implementation on Israeli children: A comparison between pre-and post-vaccination era. World J Pediatr, 2022; 18(6):417–425; doi: 10.1007/s12519-022-00547-z
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
